Bill

Bill > S2780


MA S2780

To expand access to Naloxone


summary

Introduced
03/24/2022
In Committee
01/03/2023
Crossed Over
Passed
Dead
12/31/2022

Introduced Session

192nd General Court

Bill Summary

For legislationfor legislation to expand naloxone access, reports the accompanying bill (Senate, No. 2780).

AI Summary

This bill aims to expand access to naloxone, a drug used to treat opioid overdoses. The key provisions are: 1) Practitioners who prescribe Schedule II opioids must also offer a prescription for an opioid antagonist (such as naloxone) if the patient meets certain conditions, such as being prescribed a high daily dose of opioids or also being prescribed benzodiazepines. 2) Practitioners must provide education to patients on overdose prevention and the use of opioid antagonists. 3) If a practitioner does not co-prescribe an opioid antagonist, they must document the reason or indicate the patient declined the prescription. 4) Practitioners are only required to prescribe an opioid antagonist that has been approved for use by the patient by the FDA. The goal of this bill is to increase access to naloxone and other opioid overdose reversal drugs, in order to help prevent opioid-related overdoses.

Committee Categories

Budget and Finance, Health and Social Services

Sponsors (4)

Other Sponsors (1)

Joint Committee on Public Health (J)

Last Action

New draft substituted, see S3182 (on 01/03/2023)

bill text


bill summary

Loading...

bill summary

Loading...

bill summary

Loading...